Synthesis and Biological Evaluation of Novel 2-Arylalkylthio-5-iodine-6-substituted-benzyl-pyrimidine-4(3H)-ones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

被引：10
|
作者：
Zhang, Liang [1 ]
Tang, Xiaowan [1 ]
Cao, Yuanyuan [1 ]
Wu, Shaotong [1 ]
Zhang, Yu [1 ]
Zhao, Jianxiong [1 ]
Guo, Ying [1 ]
Tian, Chao [1 ]
Zhang, Zhili [1 ]
Liu, Junyi [1 ,2 ]
Wang, Xiaowei [1 ]
机构：
[1] Peking Univ, Dept Biol Chem, Sch Pharmaceut Sci, Beijing 100191, Peoples R China
[2] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
来源：
MOLECULES | 2014年 / 19卷 / 06期
关键词：
HIV; NNRTIs; S-DABOs; IC50; docking; IMMUNODEFICIENCY-VIRUS TYPE-1; S-DABO DERIVATIVES; ANTI-HIV-1; ACTIVITY; URACIL DERIVATIVES; IN-VITRO; DESIGN; RESISTANCE; DRUGS;
D O I：
10.3390/molecules19067104
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A novel series of 2-arylalkylthio-5-iodine-6-substitutedbenzyl-pyrimidine-4(3H)-ones (S-DABOs) 8a-x had been synthesized via an efficient method. Their biological activity against HIV virus and RT assay were evaluated. Some compounds, especially 8h, 8l and 8n, displayed promising activity against HIV-1 RT with IC50 values in a range of 0.41 mu M to 0.71 mu M, which were much better than that of nevirapine. Molecular modeling studies revealed that the binding mode would be affected via forming an additional hydrogen bond by incorporating an oxygen atom on the C-2 side chain. The biological activity was in accordance with the docking results.
引用
收藏
页码：7104 / 7121
页数：18
相关论文
共 50 条
  • [41] Synthesis of pyridazino[3,4-b][1,5]benzodiazepin-5-ones and their biological evaluation as non-nucleoside HIV reverse transcriptase inhibitors
    Heinisch, G
    Huber, E
    Matuszczak, B
    Maurer, A
    Prillinger, U
    ARCHIV DER PHARMAZIE, 1997, 330 (1-2) : 29 - 34
  • [42] Non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs): a class of potent molecules enriched by a novel generation
    Pacanowski, J.
    Girard, P. -M.
    VIROLOGIE, 2008, 12 : S3 - S5
  • [43] Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Mai, A
    Sbardella, G
    Artico, M
    Ragno, R
    Massa, S
    Novellino, E
    Greco, G
    Lavecchia, A
    Musiu, C
    La Colla, M
    Murgioni, C
    La Colla, P
    Loddo, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (16) : 2544 - 2554
  • [44] Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains
    Jin, KaiJun
    Sang, YaLi
    Han, Sheng
    De Clercq, Erik
    Pannecouque, Christophe
    Meng, Ge
    Chen, FenEr
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 : 11 - 20
  • [45] Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928)
    Li, Xiao
    Gao, Ping
    Zhan, Peng
    Liu, Xinyong
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (05) : 629 - 635
  • [46] Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
    Monforte, Anna-Maria
    Ferro, Stefania
    De Luca, Laura
    Lo Surdo, Giuseppa
    Morreale, Francesca
    Pannecouque, Christophe
    Balzarini, Jan
    Chimirri, Alba
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1459 - 1467
  • [47] Design, Synthesis, and SAR of Naphthyl-Substituted Diarylpyrimidines as Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
    Liang, Yong-Hong
    Feng, Xiao-Qing
    Zeng, Zhao-Sen
    Chen, Fen-Er
    Balzarini, Jan
    Pannecouque, Christophe
    De Clercq, Erik
    CHEMMEDCHEM, 2009, 4 (09) : 1537 - 1545
  • [48] Discovery of piperidine-substituted thiazolo[5,4-d] pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors
    Kang, Dongwei
    Zhao, Tong
    Wang, Zhao
    Feng, Da
    Zhang, Heng
    Huang, Boshi
    Wu, Gaochan
    Wei, Fenju
    Zhou, Zhongxia
    Jing, Lanlan
    Zuo, Xiaofang
    Tian, Ye
    Poongavanam, Vasanthanathan
    Kongsted, Jacob
    De Clercq, Erik
    Pannecouque, Christophe
    Zhan, Peng
    Liu, Xinyong
    COMMUNICATIONS CHEMISTRY, 2019, 2 (1)
  • [49] Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors
    Dongwei Kang
    Tong Zhao
    Zhao Wang
    Da Feng
    Heng Zhang
    Boshi Huang
    Gaochan Wu
    Fenju Wei
    Zhongxia Zhou
    Lanlan Jing
    Xiaofang Zuo
    Ye Tian
    Vasanthanathan Poongavanam
    Jacob Kongsted
    Erik De Clercq
    Christophe Pannecouque
    Peng Zhan
    Xinyong Liu
    Communications Chemistry, 2
  • [50] Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Kennedy-Smith, Joshua J.
    Arora, Nidhi
    Billedeau, J. Roland
    Fretland, Jennifer
    Hang, Julie Q.
    Heilek, Gabrielle M.
    Harris, Seth F.
    Hirschfeld, Donald
    Javanbakht, Hassan
    Li, Yu
    Liang, Weiling
    Roetz, Ralf
    Smith, Mark
    Su, Guoping
    Suh, Judy M.
    Villasenor, Armando G.
    Wu, Jeffrey
    Yasuda, Dennis
    Klumpp, Klaus
    Sweeney, Zachary K.
    MEDCHEMCOMM, 2010, 1 (01) : 79 - 83
12345